Samaritan's HIV Drug Granted IND From FDA

 10.07.2008 09:15   medicalnewstoday.com

Samaritan Pharmaceuticals (OTCBB:SPHC), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, announced that it has filed an IND (Investigational New Drug) application for SP-6310 in the treatment of HIV-infected patients with abnormal cortisol levels. Following discussions and protocol agreement with U.S.

World HIV/AIDS